Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor

Inclusion Criteria

• •One of the following diagnoses:
• •2. Myelodysplasia
• •3. Aplastic anemia that is not responding to immunosuppressive therapy
• •4. Myelofibrosis, either primary or secondary to polycythemia vera
• •5. Relapsed lymphoma or Hodgkin's disease
• •6. Stage III/IV chronic lymphocytic leukemia (CLL), relapsed after or refractory to at least one fludarabine containing regimen
• •7. Acute myelogenous leukemia (AML) or acute lymphoblastic leukemia (ALL) in complete remission (CR) 2 or greater, or CR 1 with high risk features
• •No prior autologous stem cell transplant
• •Eastern Cooperative Oncology Group (ECOG) performance status of less than 2
• •Lack of 6/6 or 5/6 matched related donor OR lack of 10/10 matched unrelated donor OR no available donor in the appropriate time frame to perform a potentially curative stem cell transplant
• •Diffusing capacity of the lung for carbon monoxide (DLCO) greater than 50% of predicted value
• •Left ventricular ejection fraction (LVEF) greater than 50% of predicted value
• •Calcium levels less than 10.5 mg/dl
• •Phosphate levels greater than 1.6 mg/dl